All ingredient lists · Model report

Ingredient list

Liraglutide.

Declared composition for LIRAVEXIN catalog number LL30. This page lists what the catalog names. It is not a laboratory assay and not a test result.

Ingredient list — declared composition, not a test result
GS Laboratory

Prepared as a catalog companion to the model testing report.

Ingredient list

Declared composition for a LIRAVEXIN catalog item — not a tested result

Catalog number
LL30
Product name
Liraglutide
Labelled amount
30 mg
Pack, as catalogued
30 mg × 10 vials
Physical form
Lyophilised powder in a vial
Catalog
LIRAVEXIN (www.liravexin.com)

Declared ingredients

Ingredient Amount as declared Public identity
Liraglutide30 mgA long-acting GLP-1 receptor agonist (Arg34 GLP-1 analogue) with a palmitoyl chain attached at Lys26 via a γ-glutamate spacer.
Public sequence / structure: His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(ε-(γ-Glu-palmitoyl))-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly
Other constituents—Not declared on the catalog label. No excipient (for example a bulking agent, counter-ion or residual moisture) is assumed here.

Amino-acid sequences, where shown, are well-known public identities of the named substance. If a sequence could not be stated with confidence, it has been omitted rather than guessed.

Notes

This ingredient list is a declared composition for the catalog item. It is not a Certificate of Analysis and not a statement of purity, identity or content as measured in a laboratory.

The catalog item is a research product, not a medicinal product. This page is not medical advice, not a dosing guide, and not a marketing claim. GS Laboratory does not manufacture or sell peptides or medicines.

Declared composition — not a test result · LL30